Already have a Username/Password for Acta Orthop Traumatol Turc?
Go to Login
Need a Username/Password?
Go to Registration
Registration and login are required to submit items online and to check the status of current submissions.
Acta Orthopaedica et Traumatologica Turcica publishes diagnostic, treatment, and prevention methods related to orthopedics and traumatology and original studies in related disciplines. Contributions may be in the form of clinical and basic research articles, case reports, personal clinical and technical notes, and letters to the Editor. The Journal also publishes brief reports on original studies or evaluations, book reviews, and proceedings of scientific meetings. Opinions presented in published articles by no means represent the official endorsement of the Turkish Association of Orthopaedics and Traumatology. Articles and illustrations become the property of the Journal after publication. The Editor-in-Chief may request from the authors additional data, information, or complementary material concerning the manuscripts, and the authors must comply with such requests.
Manuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals regularly updated by the International Committee of Medical Journal Editors, available at http://www.icmje.org.
Acta Orthopaedica et Traumatologica Turcica follows the ethics flowcharts developed by the Committee on Publication Ethics (COPE) for dealing with cases of possible scientific misconduct and breach of publication ethics. For detailed information please visit http://www.publicationethics.org.
All manuscripts presenting data obtained from research involving human subjects must include a statement that the written informed consent of the participants was obtained and that the study was approved by an institutional review board or an equivalent body. This institutional approval should be submitted with the manuscript. Authors of case reports must submit the written informed consent of the subject(s) of the report or of the patient’s legal representatives for the publication of the manuscript. All studies should be carried out in accordance with the World Medical Association Declaration of Helsinki, covering the latest revision date. Patient confidentiality must be protected according to the universally accepted guidelines and rules. Manuscripts reporting the results of experimental studies on animals must include a statement that the study protocol was approved by the animal ethics committee of the institution and that the study was conducted in accordance with the internationally accepted guidelines, including the Universal Declaration of Animal Rights, European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, Principles of Laboratory Animal Science, and the Handbook for the Care and Utilization of Laboratory Animals. The authors are strongly requested to send the approval of the ethics committee together with the manuscript. In addition, manuscripts on human and animal studies should describe procedures indicating the steps taken to eliminate pain and suffering.
Submission and peer reviewing
The official language of the Journal is English. In addition, the Turkish version of the journal as a translated complete journal issue is also printed for Turkish readers. Simultaneous electronic versions of all printed articles are presented in both English and Turkish at the official web site (http://www.aott.org.tr).
Following an initial evaluation and elimination for sufficient priority, manuscripts are subject to blind peer review by at least two reviewers. The Editor, who judges and analyzes the entire review process, reaches a final decision to accept or reject a manuscript, or to recommend a revision. The Editor has the right to reject a revised manuscript.
Copyright - Authors’ approval - Conflict of interest
The authors should disclose all issues concerning financial relationship, conflict of interest, and competing interest that may potentially influence the results of the research or scientific judgement. All financial contributions or sponsorship, financial relations, and areas of conflict of interest should be clearly explained in a separate letter to the editor at the time of submission, with full assurance that any related document will be submitted to the Journal when requested.
Manuscripts should be sent with the Copyright-Authors’ Approval-Conflict of Interest Letter signed by the author(s). A copy of this letter can be found at http://www.aott.org.tr/copyright_form.pdf. Manuscripts will not be accepted for evaluation until the receipt of this document by the Journal.
Türk Ortopedi ve Travmatoloji Derneği Sekreteryası,
Şehremini Mah., Millet Cad., Renk Apt., No: 77/6,
34104 Fındıkzade, Fatih, İstanbul, Turkey
Tel: +90 212 530 15 08/21 Fax: +90 212 530 15 21
Submitting a manuscript
Submission and tracking of a manuscript can only be made through the Journal’s online system at http://www.aott.org.tr. First, the corresponding author should register to obtain a user name and password.
Five steps of the submission process are summarized below.
1. Beginning submission: First, the article type is selected that best describes the manuscript, e.g. original paper, case presentation, technical note, letter to the editor, experimental work. Then, the manuscript control list is checked to ensure nothing is missing concerning the manuscript. In this step, comments to the Editor can be entered in the designated field.
2. The record of the submission: In this step, the following information is entered in the fields provided: the names of the authors, addresses, article title and abstract, which will allow these data to appear in search engines including PubMed.
3. Loading the manuscript: The manuscript file should be loaded according to the instructions listed. IT IS OF UTMOST IMPORTANCE THAT, FOR DOUBLE-BLIND REVIEWING PROCESS, information about the authors’ identities AND INSTITUTION do not appear anywhere in the manuscript. Instructions for manuscript preparation can be found in the “Author Guidelines” section.
4. Supplementary files: In this step, other files related to the manuscript are uploaded, including figures and tables. Although the system is able to manage all types of files, “jpeg” is preferred for photos, “mpeg” for video formats. For files that should be prevented from reviewers access such as Ethics Committee Approval, and Copyright-Authors’ Approval-Conflict of Interest Letter, the check box provided in step 2 should be clicked in.
5. Verification: This final step includes checking the uploaded files and completing the submission procedure.
The author(s) must declare that they were involved in at least 3 of the 5 stages of the study stated in the “acknowledgement of authorship and transfer of copyright agreement” as “designing the study”, “collecting the data”, “analyzing the data”, “writing the manuscript” and “confirming the accuracy of the data and the analyses”. Those who do not fulfill this prerequisite should not be stated as an author.
The number of authors should not exceed 6 for clinical, basic and experimental studies, 4 for case reports and technical notes, and 3 for letters to the editor and reviews. In multi-center or multi-discipline studies, each author’s contribution regarding the 5 stages mentioned above should be stated clearly. For this kind of multi-center or multi-discipline studies with excessive number of authors, the editor has the right to request that the number of authors be reduced.
From the beginning of introduction to the end of discussion, clinical, basic and experimental studies should not exceed 2500 words, case reports and surgical techniques 1500 words, letters to the editor 350 words. Manuscripts exceeding these limits will be returned to the author(s) to be shortened.
The follow-up time of each patient should be at least 2 years for orthopedic patient series or case reports (1 year is adequate for cases with infection and tumor), and 1 year for traumatized patient series or case reports. Manuscripts with a follow-up duration below these limits will not be evaluated.
Manuscripts should be designed in the following order: title page, abstract, main text, references, and tables, with each typeset on a separate page.
Title page: This page should only include the title of the manuscript, which should be carefully chosen to better reflect the contents of the study. Author names should not appear in the title and subsequent pages.
Abstract: It should not exceed 250 words. Abstracts should be structured in four paragraphs using the following subtitles: Objectives, Methods, Results, and Conclusion. Summaries for case reports should be unstructured.
Main text: The body consists of Introduction, Patients/Materials and methods, Results, and Discussion. Use “Patients and methods” for clinical studies, and “Materials and methods” for animal and laboratory studies.
The Introduction section clearly states the purpose of the manuscript and includes a brief summary of the most relevant literature.
The Patients/Materials and methods section describes the study population and the study design, with adequate information on the techniques, materials, and methods used. A clear description of the statistical methods should also be given.
The Results section should provide a detailed report on the findings of the study. Data should be concisely presented, preferably in tables or illustrations, which should not exceed the page layout of the Journal.
The Discussion section should mainly rely on the conclusions derived from the results of the study, with relevant citations from the most recent research.
Letter to the Editor: Letters to the editor should not exceed 350 words.
References should be numbered in the order in which they are mentioned in the text. Only published articles or articles in press can be used in references. Unpublished data or personal communications should not be used. The style should conform to the standards described in detail in “Citing Medicine-The NLM Style Guide for Authors, Editors, and Publishers” (http://www.nlm.nih.gov/citingmedicine), which is recommended in the most recent update of “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”. A brief presentation of these standards can also be found at http://www.nlm.nih.gov/bsd/uniform_requirements.html. Journal titles should be abbreviated according to the Index Medicus. The Journal’s title is abbreviated as “Acta Orthop Traumatol Turc”.
The style and punctuation should follow the formats outlined below:
Standard journal article:
Geiger EV, Maier M, Kelm A, Wutzler S, Seebach C, Marzi I. Functional outcome and complications following PHILOS plate fixation in proximal humeral fractures. Acta Orthop Traumatol Turc 2010;44:1-6.
All authors if six or fewer should be listed; otherwise, the first six and “et al.” should be written.
McRea R. Clinical orthopaedic examination. 5th ed. Philadelphia: Churchill Livingstone; 2004.
Editor(s), compiler(s) as author:
Günal İ, Barton NJ, Çallı İ, editors. Current management of scaphoid fractures. Twenty questions answered. London: The Royal Society of Medicine Press; 2002.
Chapter in a book:
Wilkins K. Fractures and dislocation of the elbow region. In: Rockwood CA, Wilkins KE, King RE, editors. Fractures in children. Vol. 3, 3rd ed. New York: Lippincott; 1991. p. 509-828.
Kouzelis A, Matzaroglou C, Kravvas A, Mylonas S, Megas P, Gliatis J. Anterior cruciate ligament reconstruction: patellar tendon autogaft versus four strand hamstring tendon. In: Proceedings of the 9th Turkish Sports Traumatology, Arthroscopy and Knee Surgery Congress; 2008 Oct 14-18; İstanbul, Turkey. p. 223.
Unpublished conference papers should not be used in the reference list.
Direct use of references is strongly recommended and the authors may be asked to provide the first and last pages of certain references. Publication of the manuscript will be suspended until this request is fulfilled by the author(s).
Figures and tables
All illustrations (photographs, graphics, and drawings) accompanying the manuscript should be referred to as “figure”. All figures should be numbered consecutively and mentioned in the text. Figure legends should be added at the end of the text as a separate section. Each figure should be prepared as a separate digital file in “jpeg” format, with a minimum of 9x13 cm and at 600 dpi or better resolution.
All illustrations should be original. Illustrations published elsewhere should be submitted with the written permission of the original copyright holder.
For recognizable photographs of human subjects, written permission signed by the patient or his/her legal representative should be submitted; otherwise, patient names or eyes must be blocked out to prevent identification. Microscopic photographs should include information on staining and magnification.
Upon the author’s request, color prints will be considered for publication; however, the authors are responsible for the extra cost of printing color illustrations.
Each table should be prepared on a separate page, either at the end of the text file or as a separate supplementary file, with table heading on top of the table. Table heading should be added to the main text file on a separate page when a table is submitted as a supplementary file.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- Title page with NO INFORMATION about the authors
- Abstract in English, structured, 250 words or shorter
- References, listed in order of citation
- All figures and tables are cited in the manuscript
- A letter of copyright transfer, signed by all authors (to upload as a supplementary file)
All published material will become the sole property and will be copyrighted by the Journal. No part of the publication may be used without prior written permission of the publisher.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.